Melatonin for primary insomnia?

Review Drug and therapeutics bulletin 2009

<\/script>\n

`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D19567841'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

Tipo di studio: Review
Popolazione: None

Intervento: Melatonin for primary insomnia? None
Comparatore: None
Esito primario: Melatonin for primary insomnia?
Direzione dell'effetto: Mixed
Rischio di bias: Unclear

Abstract

Melatonin, a hormone produced by the pineal gland, has a key role in regulating circadian rhythms, most importantly, the sleep-wake cycle. Melatonin's action has led to its being tried as a treatment for a wide range of sleep disorders, such as jet lag, primary insomnia, sleep-wake cycle disruption and sleep problems in children with neuro-developmental disorders. Until recently, it had not been licensed in the UK for any indication. Prolonged-release melatonin (Circadin - Lundbeck) has now been licensed as a treatment for primary insomnia. Here we consider whether this product has a place in the management of people with this condition.

TL;DR

Prolonged-release melatonin (▼Circadin – Lundbeck) has now been licensed as a treatment for primary insomnia and it is considered whether this product has a place in the management of people with this condition.

Used In Evidence Reviews

A Melatonin per Insonnia

A Melatonin per Jet lag

Melatonin for primary insomnia?

Embed This Widget

Study Design

Abstract

TL;DR

Used In Evidence Reviews

Similar Papers

European guideline for the diagnosis and treatment of insomnia.

Circadian typology: a comprehensive review.

Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

Regulation of terminal differentiation of cultured human keratinocytes by vitamin A.

Role of melatonin in the regulation of human circadian rhythms and sleep.